The global short-read sequencing market size accounted for USD 8.93 billion in 2024, grew to USD 10.63 billion in 2025 and is projected to surpass around USD 51.01 billion by 2034, representing a healthy CAGR of 19.04% between 2024 and 2034. The North America short-read sequencingmarket size is calculated at USD 4.47 billion in 2024 and is expected to grow at a fastest CAGR of 19.14% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Short-read Sequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Short-read Sequencing Market, by Technology, 2024-2034
8.1.1. Next-Generation Sequencing
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Sanger Sequencing
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Short-read Sequencing Market, by Workflow, 2024-2034
9.1.1. Pre-Sequencing
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Data Analysis
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Short-read Sequencing Market, by Product, 2024-2034
10.1.1. Instruments
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Consumables
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Services
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Short-read Sequencing Market, by Application, 2024-2034
11.1.1. Clinical Investigation
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Reproductive Health
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Consumer Genomics
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Agri genomics and Forensics
11.1.5.1. Market Revenue and Forecast (2021-2034)
11.1.6. HLA Typing/ Immune System Monitoring
11.1.6.1. Market Revenue and Forecast (2021-2034)
12.1. Short-read Sequencing Market, by End User, 2024-2034
12.1.1. Academic Research
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Hospital and Clinics
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Clinical Research
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Pharmaceutical and Biotechnology Companies
12.1.4.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Technology (2021-2034)
13.1.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.1.3. Market Revenue and Forecast, by Product (2021-2034)
13.1.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technology (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technology (2021-2034)
13.2.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.2.3. Market Revenue and Forecast, by Product (2021-2034)
13.2.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.5. Market Revenue and Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technology (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Product (2021-2034)
13.2.7. Market Revenue and Forecast, by Application (2021-2034)
13.2.8. Market Revenue and Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technology (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Product (2021-2034)
13.2.10. Market Revenue and Forecast, by Application (2021-2034)
13.2.11. Market Revenue and Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technology (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.13. Market Revenue and Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technology (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.15. Market Revenue and Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technology (2021-2034)
13.3.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.3.3. Market Revenue and Forecast, by Product (2021-2034)
13.3.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technology (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.7. Market Revenue and Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technology (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.9. Market Revenue and Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technology (2021-2034)
13.4.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.4.3. Market Revenue and Forecast, by Product (2021-2034)
13.4.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technology (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.7. Market Revenue and Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technology (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.9. Market Revenue and Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technology (2021-2034)
13.5.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.5.3. Market Revenue and Forecast, by Product (2021-2034)
13.5.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.5. Market Revenue and Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technology (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.7. Market Revenue and Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Workflow (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)
14.1. BGI
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ProPhase Labs, Inc. (Nebula Genomics)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Illumina, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Psomagen
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. QIAGEN
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Azenta US, Inc. (GENEWIZ)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. PerkinElmer, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Pacific Biosciences of California, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample